Cacti Asset Management Trimmed Its Boeing Co (BA) Position; Lantheus Holdings (LNTH) Sellers Increased By 5.91% Their Shorts

Cacti Asset Management Llc decreased Boeing Co (BA) stake by 2.53% reported in 2017Q3 SEC filing. Cacti Asset Management Llc sold 6,670 shares as Boeing Co (BA)’s stock rose 4.66%. The Cacti Asset Management Llc holds 257,135 shares with $65.37M value, down from 263,805 last quarter. Boeing Co now has $202.55B valuation. The stock decreased 2.91% or $10.33 during the last trading session, reaching $344.19. About 6.09M shares traded or 10.60% up from the average. The Boeing Company (NYSE:BA) has risen 41.13% since March 13, 2017 and is uptrending. It has outperformed by 24.43% the S&P500.

Lantheus Holdings Inc (NASDAQ:LNTH) had an increase of 5.91% in short interest. LNTH’s SI was 562,900 shares in March as released by FINRA. Its up 5.91% from 531,500 shares previously. With 269,600 avg volume, 2 days are for Lantheus Holdings Inc (NASDAQ:LNTH)’s short sellers to cover LNTH’s short positions. The SI to Lantheus Holdings Inc’s float is 1.56%. The stock increased 5.00% or $0.8 during the last trading session, reaching $16.8. About 348,180 shares traded. Lantheus Holdings, Inc. (NASDAQ:LNTH) has risen 644.29% since March 13, 2017 and is uptrending. It has outperformed by 627.59% the S&P500.

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic medical imaging agents and products for the diagnosis and treatment of cardiovascular and other diseases worldwide. The company has market cap of $636.06 million. The Company’s principal products include DEFINITY, an ultrasound contrast imaging agent for use in patients with suboptimal echocardiograms; TechneLite, a self-contained system or generator of technetium used by radiopharmacies to prepare various nuclear imaging agents; and Xenon, a radiopharmaceutical gas used to assess pulmonary function and imaging of cerebral blood flow. It has a 5.3 P/E ratio. The firm also offers injectable technetium-labeled imaging agents, including Cardiolite, used in myocardial perfusion imaging procedures; and Neurolite, which is used to identify the area in the brain where blood flow has been blocked or reduced due to stroke.

Among 6 analysts covering Lantheus Holdings (NASDAQ:LNTH), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. Lantheus Holdings has $27.0 highest and $4 lowest target. $18’s average target is 7.14% above currents $16.8 stock price. Lantheus Holdings had 16 analyst reports since August 31, 2015 according to SRatingsIntel. Jefferies maintained Lantheus Holdings, Inc. (NASDAQ:LNTH) rating on Friday, November 3. Jefferies has “Buy” rating and $27.0 target. RBC Capital Markets maintained the shares of LNTH in report on Wednesday, February 24 with “Outperform” rating. The stock of Lantheus Holdings, Inc. (NASDAQ:LNTH) earned “Neutral” rating by Credit Suisse on Friday, December 11. The stock of Lantheus Holdings, Inc. (NASDAQ:LNTH) earned “Neutral” rating by Credit Suisse on Wednesday, August 2. Wells Fargo upgraded the stock to “Buy” rating in Thursday, November 2 report. The company was downgraded on Wednesday, September 30 by Wells Fargo. Jefferies maintained the shares of LNTH in report on Tuesday, October 10 with “Buy” rating. The firm has “Neutral” rating by Credit Suisse given on Friday, September 23. The rating was maintained by Credit Suisse with “Neutral” on Friday, November 3. The stock of Lantheus Holdings, Inc. (NASDAQ:LNTH) earned “Buy” rating by Jefferies on Thursday, June 29.

Analysts await The Boeing Company (NYSE:BA) to report earnings on April, 25. They expect $2.73 earnings per share, up 35.82% or $0.72 from last year’s $2.01 per share. BA’s profit will be $1.61 billion for 31.52 P/E if the $2.73 EPS becomes a reality. After $4.80 actual earnings per share reported by The Boeing Company for the previous quarter, Wall Street now forecasts -43.13% negative EPS growth.

Investors sentiment decreased to 0.79 in Q3 2017. Its down 0.02, from 0.81 in 2017Q2. It turned negative, as 50 investors sold BA shares while 609 reduced holdings. 165 funds opened positions while 367 raised stakes. 411.79 million shares or 1.95% less from 419.99 million shares in 2017Q2 were reported. Moreover, Argent Trust has 0.54% invested in The Boeing Company (NYSE:BA) for 5,354 shares. East Coast Asset Limited Co holds 0.21% or 3,225 shares. 10,539 are owned by Charter Tru. Mitchell Mcleod Pugh Williams, a Alabama-based fund reported 4,071 shares. Clearbridge Investments Limited Liability accumulated 284,984 shares. Alps Advsr Incorporated reported 0.01% stake. Carnegie Asset Ltd Liability Com invested in 52,859 shares or 1.62% of the stock. Stratos Wealth Ptnrs Ltd holds 0.18% or 15,247 shares in its portfolio. 4,325 are owned by Cap Wealth Planning Ltd. Toronto Dominion Comml Bank holds 0.18% or 225,782 shares. S R Schill & Assoc owns 4,336 shares. The Minnesota-based Gradient Investments Ltd Company has invested 0.04% in The Boeing Company (NYSE:BA). Meeder Asset Mngmt Inc holds 28,240 shares or 0.78% of its portfolio. Two Sigma Secs Llc invested in 0.08% or 3,642 shares. Ww Invsts accumulated 30.50M shares.

Among 25 analysts covering Boeing (NYSE:BA), 17 have Buy rating, 1 Sell and 7 Hold. Therefore 68% are positive. Boeing has $470.0 highest and $125 lowest target. $335.18’s average target is -2.62% below currents $344.19 stock price. Boeing had 104 analyst reports since August 26, 2015 according to SRatingsIntel. Credit Suisse upgraded the shares of BA in report on Thursday, July 27 to “Outperform” rating. The firm has “Buy” rating by Seaport Global given on Wednesday, January 3. The rating was maintained by Canaccord Genuity with “Hold” on Friday, April 28. RBC Capital Markets maintained The Boeing Company (NYSE:BA) on Friday, February 12 with “Sector Perform” rating. On Thursday, October 6 the stock rating was initiated by Robert W. Baird with “Outperform”. The company was maintained on Wednesday, October 18 by Canaccord Genuity. The stock of The Boeing Company (NYSE:BA) has “Buy” rating given on Friday, February 2 by Tigress Financial. The rating was maintained by RBC Capital Markets with “Hold” on Wednesday, January 31. The company was maintained on Tuesday, June 13 by Cowen & Co. The firm earned “Buy” rating on Monday, September 19 by Citigroup.